treatments in Czech Republic
Combination Carfilzomib and dexamethasone
| Available in Czech Republic? |  |
| Reimbursement status | No |
| Available compassionate use programmes (adults & children) |  |
Combination Carfilzomib, lenalidomide and dexamethasone
| Available in Czech Republic? | |
| Reimbursement status | Yes |
| Available compassionate use programmes (adults & children) | |
Bortezomib in combination with thalidomide and dexamethasone
| Available in Czech Republic? | |
| Reimbursement status | Yes |
| Available compassionate use programmes (adults & children) | |
Bortezomib in combination with melphalan and prednisolone
| Available in Czech Republic? | |
| Reimbursement status | Yes |
| Available compassionate use programmes (adults & children) | |
Bortezomib as a monotherapy
| Available in Czech Republic? | |
| Reimbursement status | Yes |
| Available compassionate use programmes (adults & children) | |
Daratumumab in combination with bortezomib and dexamethasone
| Available in Czech Republic? | |
| Reimbursement status | No |
| Available compassionate use programmes (adults & children) | |
Daratumumab in combination with lenalidomide and dexamethasone
| Available in Czech Republic? | |
| Reimbursement status | Yes |
| Available compassionate use programmes (adults & children) | |
Daratumumab as a monotherapy
| Available in Czech Republic? | |
| Reimbursement status | No |
| Available compassionate use programmes (adults & children) | |
Elotuzumab in combination with lenalidomide and dexamethasone
| Available in Czech Republic? | |
| Reimbursement status | No |
| Available compassionate use programmes (adults & children) | |
Ixazomib in combination with lenalidomide and dexamethasone
| Available in Czech Republic? | |
| Reimbursement status | No |
| Available compassionate use programmes (adults & children) | |
Lenalidomide combination with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone
| Available in Czech Republic? | |
| Reimbursement status | Yes |
| Available compassionate use programmes (adults & children) | |
Lenalidomide as a monotherapy
| Available in Czech Republic? | |
| Reimbursement status | No |
| Available compassionate use programmes (adults & children) | |
Panobinostat in combination with bortezomib and dexamethasone
| Available in Czech Republic? | |
| Reimbursement status | No |
| Available compassionate use programmes (adults & children) | |
Pomalidomide in combination with bortezomib and dexamethasone
| Available in Czech Republic? | |
| Reimbursement status | Yes |
| Available compassionate use programmes (adults & children) | |
Thalidomide as a monotherapy
| Available in Czech Republic? | |
| Reimbursement status | No |
| Available compassionate use programmes (adults & children) | |
1
on-going clinical trials
As of November 2020, there are no recruiting nor active, not recruiting clinical trials on Multiple Myeloma in the country.
Click here to access a list of Multiple Myeloma clinical trials in Europe.
ERN Centers in Czech Republic
ERN centres part of European network for Rare Hematological Diseases – EuroBloodNet. More information is available on EuroBloodNet official website.
- University hospital Brno
ihlavská 340/20
625 00 Brno-Bohunice-Brno-Starý Lískovec
Ph.: +420 532 231 111
https://www.fnbrno.cz